Metformin misuse in chronic kidney disease.

Diabetes Metab

Department of nephrology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.

Published: September 2020

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabet.2018.07.005DOI Listing

Publication Analysis

Top Keywords

metformin misuse
4
misuse chronic
4
chronic kidney
4
kidney disease
4
metformin
1
chronic
1
kidney
1
disease
1

Similar Publications

Lifestyle and Pharmacologic Approaches to Prevention of MASLD-related HCC.

Clin Gastroenterol Hepatol

January 2025

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address:

Hepatocellular carcinoma (HCC) is a major concern for public health. Fatty liver disease, related to alcohol misuse or metabolic syndrome, has become the leading cause of chronic liver disease and HCC. The strong association between type 2 diabetes mellitus and HCC can be partly attributed to the development of metabolic dysfunction associated steatotic liver disease (MASLD).

View Article and Find Full Text PDF

A 65-year-old man with type 2 diabetes who was being treated with metformin developed lactic acidosis following excessive alcohol consumption. While an impaired renal function is a major risk factor for metformin-associated lactic acidosis (MALA), the patient's basal renal function was normal. Alcohol misuse reduces lactate clearance by utilizing nicotinamide adenine dinucleotides for ethanol oxidation, thereby promoting vulnerability to MALA.

View Article and Find Full Text PDF

COVID19 has caused a significant socioeconomic burden worldwide. Opioid crisis was further intensified with the increasing number of opioid overdose/misuse related deaths in last two years. Abusers have adopted newer/efficient methods for manipulating and abusing commercial opioid formulations.

View Article and Find Full Text PDF

Cross Referencing 2D-LC Determination of Intact Gliptins in Urine.

J Chromatogr Sci

October 2020

Department of Analytical Chemistry, Faculty of Pharmacy, Istanbul University, 7-1, Suleymaniye, 34116, Istanbul, Turkey.

Dipeptidyl peptidase-4 inhibitors, so-called gliptins, constitute a fairly novel class of oral hypoglycemic agents. The development and validation of an automated online SPE-LC-UV method to determine intact sitagliptin, saxagliptin, vildagliptin and metformin simultaneously in human urine samples were performed. For the two-dimensional chromatographic separation, a Gemini C18 (250.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!